Investing.com -- Essentra Plc (LON:ESNT) on Thursday reported its full-year 2025 pre-close trading update showing performance in line with market expectations, with management guiding for FY25 EBITA to match consensus.
The components and solutions provider delivered approximately 5% year-over-year organic constant currency growth during the fourth quarter, primarily driven by strong performance in the EMEA region. Order intake also improved in Q4, while year-end net debt remained in line with management’s expectations.
Integration of the recently acquired Device Technologies business is "progressing as expected," according to the company. The acquisition was completed in December 2025.
For the full year 2025, Essentra expects to achieve 2.5% organic constant currency sales growth, while reported sales are anticipated to be flat year-over-year. The company maintained its EBITA margin at 10.8%, consistent with the first half of 2025.
Regional performance varied across markets. EMEA delivered high single-digit organic constant currency sales growth, benefiting particularly from strong performance in Turkey.
The Americas region achieved low single-digit growth in Q4, supported by pricing initiatives and stable distributor channels. Meanwhile, the Asia-Pacific region experienced a slight decline due to one-off projects in the prior year and market dynamics in China.
Cash generation remained "strong" throughout the period, with pre-IFRS leverage expected to close within the target of less than 1.5x. The company noted it has sufficient headroom to support operational and strategic growth initiatives in FY26.
Essentra expects to deliver FY25 EBITA in line with market expectations of £32.0m-£32.4m. The company’s shares closed at 96.30p, with analysts at Jefferies maintaining a Buy rating and a price target of 150.00p, representing 56% upside potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

























